Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.546    -0.034 (-5.86%)
Bid:
0.55
Ask:
0.60
Spread: 0.05 (9.091%)
Market Cap: £3.17m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Block Listing Update

11 May 2015 07:00

RNS Number : 7123M
Futura Medical PLC
11 May 2015
 

For immediate release

11 May 2015

 

 

 

Futura Medical plc

("Futura" or "the Company")

 

Block Listing Update

 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in November 2014, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans. All ordinary shares of 0.2 pence each.

The table below provides further detail.

 

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")EMI Share Option Scheme ("EMI")

 

Period of return:

From:

11 November 2014

To:

11 May 2015

 

Number and class of securities not issued under the scheme(s)

USOS:

1,786,435

EMI:

1,828,306

Total:

3,614,741

 

 

Number of securities issued under the scheme(s) during the period

 

 

Number of securities lapsed under the scheme(s) during the period

USOS:

Nil

EMI:

 

 

USOS:

EMI:

Total:

Nil

 

 

345,835

434,165

780,000

 

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

 

Number and class of securities originally admitted and the date of admission

USOS:

814,424 on 25 May 2011 and 1,202,280 on 8 October 2013

Total:

2,016,704 Total

EMI:

1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013

Total:

2,988,296 Total

Total:

5,005,000

 

 

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

 

 

For further information please contact:

 

Futura Medical plc

James Barder, Chief Executive

+ 44 (0) 1483 685 670

james.barder@futuramedical.com

www.futuramedical.com

 

 

N+1 Singer (Nominated Adviser and Broker)Aubrey Powell / Thomas Smale+44 (0) 20 7496 3000

For media enquiries please contact:

 

Buchanan

Mark Court / Sophie Cowles / Stephanie Watson

+ 44 (0) 20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRGGUPGAUPAGRU
Date   Source Headline
24th Apr 20257:00 amRNSChange of Broker
15th Apr 20257:00 amRNSResults for the Year ended 31 December 2024
10th Apr 20251:30 pmRNSNotice of Results and Investor Presentation
31st Mar 20257:00 amRNSBoard Appointment
30th Jan 20257:00 amRNSFY24 Trading Update and FY25 Outlook
15th Jan 20257:00 amRNSPositive results from WSD4000 Home User study
13th Jan 20257:00 amRNSRemuneration of Non-Executive Directors and TVR's
20th Dec 20247:58 amRNSHolding(s) in Company
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
15th Nov 20247:00 amRNSTR-1: Notification of major holdings
4th Nov 20247:00 amRNSEncouraging New Product Development Pipeline
31st Oct 20247:00 amRNSTotal Voting Rights
7th Oct 20247:00 amRNSFurther milestone payment triggered post US launch
1st Oct 20247:00 amRNSTotal Voting Rights
13th Sep 20247:00 amRNSDirectors’ / PDMR Dealing
11th Sep 20245:43 pmRNSTrinity Delta research note & consensus forecasts
10th Sep 20247:00 amRNSFutura Medical - Interim Results 2024
2nd Sep 202410:47 amRNSUpdate on US Launch
2nd Sep 20247:00 amRNSUpdate on US launch
19th Aug 20247:00 amRNSNotice of Results
1st Aug 20247:05 amRNSUpdate on US launch
1st Jul 20242:13 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSNominated Adviser and Joint Broker
20th Jun 20244:12 pmRNSResult of AGM
20th Jun 20247:00 amRNSAGM Statement
31st May 20247:00 amRNSBlock Listing Six Monthly Review
24th May 20247:00 amRNSNotice of AGM and availability of Annual Report
29th Apr 20247:00 amRNSDirectors’ / PDMR Dealing and Grant of Options
10th Apr 20247:00 amRNSResults for the Year ended 31 December 2023
25th Mar 20247:00 amRNSNotice of Results and Investor Presentation
14th Feb 20247:00 amRNSEroxon to be available on prescription
6th Feb 20247:01 amRNSTrading Update
6th Feb 20247:00 amRNSAppointment of Joint Corporate Broker
17th Jan 20247:00 amRNSDirector/PDMR Dealing
17th Jan 20247:00 amRNSRemuneration of Non-Exec Directors & Voting Rights
15th Jan 20247:00 amRNSFutura Medical extends collaboration with Cooper
9th Jan 20247:00 amRNSAppointment of Roy Davis as Non-Executive Director
30th Nov 20233:10 pmRNSTotal Voting Rights
30th Nov 20233:10 pmRNSBlock Listing Six Monthly Return
7th Nov 20237:00 amRNSFutura expands partnership with M8 Pharmaceuticals
2nd Nov 20233:34 pmRNSEroxon Awarded “New Product of the Year” by Boots
31st Oct 20237:00 amRNSBlock Listing Application and Total Voting Rights
25th Oct 20237:00 amRNSEroxon® Granted Marketing Authorisation in Mexico
19th Oct 20237:00 amRNSEroxon Launches in the United Arab Emirates
10th Oct 20237:00 amRNSDirectors’/PDMR Dealing and Grant of Options
2nd Oct 20237:00 amRNSEuropean Patent Granted for MED3000 until 2040
18th Sep 20237:00 amRNSFutura Medical - Interim Results 2023
18th Aug 20237:00 amRNSFutura Medical - Notice of Interim Results
31st Jul 20237:00 amRNSFutura Medical - Total Voting Rights
18th Jul 202311:04 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.